Evidence map›Paper›PMID 37107081›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Observation of Cytotoxicity of Phosphonium Derivatives Is Explained: Metabolism Inhibition and Adhesion Alteration.

Pavel A Nazarov, Svetlana A Khrulnova, Andrew G Kessenikh, Uliana S Novoyatlova, Svetlana B Kuznetsova, Sergey V Bazhenov, Alexandra I Sorochkina, Marina V Karakozova, Ilya V Manukhov

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Pavel A NazarovMoscow Institute of Physics and Technology,141700 Dolgoprudny, Russia.ORCID 0000-0003-1857-323X
Svetlana A KhrulnovaMoscow Institute of Physics and Technology,141700 Dolgoprudny, Russia.
Andrew G KessenikhMoscow Institute of Physics and Technology,141700 Dolgoprudny, Russia.
Uliana S NovoyatlovaMoscow Institute of Physics and Technology,141700 Dolgoprudny, Russia.
Svetlana B KuznetsovaMoscow Institute of Physics and Technology,141700 Dolgoprudny, Russia.
Sergey V BazhenovMoscow Institute of Physics and Technology,141700 Dolgoprudny, Russia.
Alexandra I SorochkinaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992 Moscow, Russia.
Marina V KarakozovaCenter of Life Sciences, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia.
Ilya V ManukhovMoscow Institute of Physics and Technology,141700 Dolgoprudny, Russia.
Moscow Institute of Physics and Technology · RULomonosov Moscow State University · RUSkolkovo Institute of Science and Technology · RU

Funding

Russian Foundation for Basic Research 20-015-00537Russian Science Foundation 22-14-00124
6 · The paper itself

Abstract

The search for new antibiotics, substances that kill prokaryotic cells and do not kill eukaryotic cells, is an urgent need for modern medicine. Among the most promising are derivatives of triphenylphosphonium, which can protect the infected organs of mammals and heal damaged cells as mitochondria-targeted antioxidants. In addition to the antioxidant action, triphenylphosphonium derivatives exhibit antibacterial activity. It has recently been reported that triphenylphosphonium derivatives cause either cytotoxic effects or inhibition of cellular metabolism at submicromolar concentrations. In this work, we analyzed the MTT data using microscopy and compared them with data on changes in the luminescence of bacteria. We have shown that, at submicromolar concentrations, only metabolism is inhibited, while an increase in alkyltriphenylphosphonium (CnTPP) concentration leads to adhesion alteration. Thus, our data on eukaryotic and prokaryotic cells confirm a decrease in the metabolic activity of cells by CnTPPs but do not confirm a cytocidal effect of TPPs at submicromolar concentrations. This allows us to consider CnTPP as a non-toxic antibacterial drug at low concentrations and a relatively safe vector for delivering other antibacterial substances into bacterial cells.

Indexed as

antibioticbioluminescencebiosensorcytostaticcytotoxicityMTT testphosphonium

Identifiers

PMID37107081
PMCPMC10135132
OpenAlexW4362664825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.